Literature DB >> 12048028

Mouse resident peritoneal macrophages partially control in vitro infection with Coxiella burnetii phase II.

Dario S Zamboni1, Renato A Mortara, Edna Freymuller, Michel Rabinovitch.   

Abstract

Coxiella burnetii, the agent of Q fever in man and of coxiellosis in other species, is a small, dimorphic, obligate intracellular bacterium, sheltered within large, acidified, and hydrolase-rich phagosomes. Although several primary and established cell lines, macrophage-like cells, and primary macrophages from other species have been infected with C. burnetii, the infection of mouse primary macrophages has not been sufficiently characterized. In this report quantification of DAPI (4', 6-diamino-2-phenylindole) fluorescence images acquired by confocal microscopy, and transmission electron microscopy were used to compare the infection of three mouse-derived cells, L929 fibroblasts, J774 macrophage-like cells, and resident peritoneal macrophages, with a phase II clone of C. burnetii known to be non-virulent for mammals. Infected peritoneal phagocytes differed from L929 or J774 cells in that: (a) large vacuoles took longer to appear (3-5 d instead of 2), and were only found in a subset (20-30%) of macrophages, as opposed to in more than 70% of the other cells; (b) total and vacuole-associated relative bacterial loads in L929 and J774 cells were several-fold higher than in peritoneal macrophages; (c) estimated doubling times of the bacteria were about 68 h in the primary macrophages, 18 h in J774 and 22 h in L929 cells. Thus, mouse resident peritoneal macrophages control both the formation of the large vacuoles and the intracellular proliferation of C. burnetii phase II.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048028     DOI: 10.1016/s1286-4579(02)01577-0

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  14 in total

1.  Complete genome sequence of the Q-fever pathogen Coxiella burnetii.

Authors:  Rekha Seshadri; Ian T Paulsen; Jonathan A Eisen; Timothy D Read; Karen E Nelson; William C Nelson; Naomi L Ward; Hervé Tettelin; Tanja M Davidsen; Maureen J Beanan; Robert T Deboy; Sean C Daugherty; Lauren M Brinkac; Ramana Madupu; Robert J Dodson; Hoda M Khouri; Kathy H Lee; Heather A Carty; David Scanlan; Robert A Heinzen; Herbert A Thompson; James E Samuel; Claire M Fraser; John F Heidelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

2.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

3.  Coxiella burnetii Blocks Intracellular Interleukin-17 Signaling in Macrophages.

Authors:  Tatiana M Clemente; Minal Mulye; Anna V Justis; Srinivas Nallandhighal; Tuan M Tran; Stacey D Gilk
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

4.  Primary Role for Toll-Like Receptor-Driven Tumor Necrosis Factor Rather than Cytosolic Immune Detection in Restricting Coxiella burnetii Phase II Replication within Mouse Macrophages.

Authors:  William P Bradley; Mark A Boyer; Hieu T Nguyen; L Dillon Birdwell; Janet Yu; Juliana M Ribeiro; Susan R Weiss; Dario S Zamboni; Craig R Roy; Sunny Shin
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

5.  Genetic susceptibility and caspase activation in mouse and human macrophages are distinct for Legionella longbeachae and L. pneumophila.

Authors:  Rexford Asare; Marina Santic; Ivana Gobin; Miljenko Doric; Jill Suttles; James E Graham; Christopher D Price; Yousef Abu Kwaik
Journal:  Infect Immun       Date:  2007-01-29       Impact factor: 3.441

6.  Nitric oxide partially controls Coxiella burnetii phase II infection in mouse primary macrophages.

Authors:  Dario S Zamboni; Michel Rabinovitch
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.

Authors:  Javier Ochoa-Repáraz; Jami Sentissi; Theresa Trunkle; Carol Riccardi; David W Pascual
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

8.  Human autoantibodies to diacyl-phosphatidylethanolamine recognize a specific set of discrete cytoplasmic domains.

Authors:  C C F C Laurino; M J Fritzler; R A Mortara; N P Silva; I C Almeida; L E C Andrade
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

9.  Murine Alveolar Macrophages Are Highly Susceptible to Replication of Coxiella burnetii Phase II In Vitro.

Authors:  Talita D Fernandes; Larissa D Cunha; Juliana M Ribeiro; Liliana M Massis; Djalma S Lima-Junior; Hayley J Newton; Dario S Zamboni
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

10.  Phagocytosis of apoptotic cells increases the susceptibility of macrophages to infection with Coxiella burnetii phase II through down-modulation of nitric oxide production.

Authors:  Dario S Zamboni; Michel Rabinovitch
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.